Capital Markets

Company Overview of Seventure Partners

Company Overview

Seventure Partners is a private equity and venture capital firm specializing in investments in various stages of development including seed, start-up, early venture, mid venture, late venture, later stage, pre IPO, growth, development capital, buyout and leveraged buyout investments. The firm typically invests in hardware and telecom with a focus on micro and nano-electronics, digital technologies, telecom infrastructures, machine to machine, smart grid, fixed-mobile convergence, and mobility and embedded systems; information and communication technology; software and Internet with a focus on tools and technologies for the Internet including platforms and software for websites, command and o...

Seventure Partners is a private equity and venture capital firm specializing in investments in various stages of development including seed, start-up, early venture, mid venture, late venture, later stage, pre IPO, growth, development capital, buyout and leveraged buyout investments. The firm typically invests in hardware and telecom with a focus on micro and nano-electronics, digital technologies, telecom infrastructures, machine to machine, smart grid, fixed-mobile convergence, and mobility and embedded systems; information and communication technology; software and Internet with a focus on tools and technologies for the Internet including platforms and software for websites, command and outsourcing of the business process, Internet marketing tools, valuation of social network traffic, semiconductors, and revenue-generating solutions, e-commerce and internet services including dematerialization of traditional trades, large markets with very strong growth on the Internet, disintermediation of the value chain, and integrated services and command of sourcing, online services, software and services to businesses including trade applications with strong added value, editors of SaaS software, and unified and progressive software platforms; life sciences with a focus on medical research, drugs including biotech drugs, lifestyle healthcare, digital health, personalised medicine, pharmaceuticals, bio-energy, vaccines, delivery systems, microbiome, intestinal infections, nutrition, regenerative medicine, cell therapy, and biomarkers and metagenomics, drug delivery systems, medical devices - implants and solutions for surgery including implants (cardiovascular, orthopedic, dental, ophthalmologic, ENT, etc.), surgical robotics, innovative surgical systems, and devices for new therapeutic approaches, medical devices - diagnostic and imaging including innovative medical imaging, in vitro diagnostic products, point of care diagnostic devices, and non-invasive diagnostics, nutrition including microbiota dysbiosis related solutions, medical nutrition, dietary foods for special medical purposes, nutraceuticals, functional foods, prevention of diseases through diet, food for special populations (seniors, obese, diabetic), dietetics, lifestyle and cosmetics, quality of life including innovative wellness device, personal care and services, dependency support, and products and services for disability compensation, aging, pathological conditions, industrial biotechnology and clean-tech including bioprocesses, biomaterials, chemistry, med-tech, white biotech, renewable energy, environment, and water and waste treatment. It typically invests in companies based in Europe including France, Scandinavia, Germany and Austria, Belgium, Luxembourg, Netherlands, United Kingdom, Finland, Norway, Sweden, Denmark, and southern Switzerland. Within life sciences, the firm prefers to invest across Europe, with a focus on France and on the Northern Europe countries. It also seeks to invest in the United States of America, Canada, and Asia. It typically invests between €0.1 million ($0.13 million) and €10 million ($13.16 million) in companies with sales up to €20000 million ($26336.80 million) . It seeks to have a board seat and a supervisory board position in its portfolio companies. The firm mostly invests as a leader, but it also acts as a follower in some of its investments, alongside other international investors. Seventure Partners was founded in 1997 and is based in Paris, France with additional offices in London, United Kingdom; Basel, Switzerland; Nyon, Switzerland; and Munich, Germany. It operates as a subsidiary of Natixis Private Equity.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.